These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24743429)

  • 1. Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.
    Zhang C; Li Y; Wang C; Wu Y; Cui W; Miwa T; Sato S; Li H; Song WC; Du J
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1240-8. PubMed ID: 24743429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH; Ruan CC; Ge Q; Ma Y; Xu JZ; Zhang ZB; Lin JR; Chen DR; Zhu DL; Gao PJ
    Circ Res; 2018 Mar; 122(7):970-983. PubMed ID: 29437833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
    Zhang C; Li Y; Wang C; Wu Y; Du J
    Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
    Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
    Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
    Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
    Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
    Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation.
    Wang L; Li YL; Zhang CC; Cui W; Wang X; Xia Y; Du J; Li HH
    Cardiovasc Res; 2014 Mar; 101(3):383-92. PubMed ID: 24259498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1
    Lin QY; Lang PP; Zhang YL; Yang XL; Xia YL; Bai J; Li HH
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1301-H1311. PubMed ID: 31729904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
    Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
    Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension.
    Weiss S; Rosendahl A; Czesla D; Meyer-Schwesinger C; Stahl RA; Ehmke H; Kurts C; Zipfel PF; Köhl J; Wenzel UO
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1356-65. PubMed ID: 27053686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice.
    Wang Y; Li Y; Wu Y; Jia L; Wang J; Xie B; Hui M; Du J
    Endocrinology; 2014 Jul; 155(7):2677-87. PubMed ID: 24877626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
    Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice.
    Ruan CC; Ge Q; Li Y; Li XD; Chen DR; Ji KD; Wu YJ; Sheng LJ; Yan C; Zhu DL; Gao PJ
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):598-606. PubMed ID: 25573852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling.
    Huang XR; Chung AC; Yang F; Yue W; Deng C; Lau CP; Tse HF; Lan HY
    Hypertension; 2010 May; 55(5):1165-71. PubMed ID: 20231525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice.
    de Haan JJ; Bosch L; Borgman A; Bastemeijer M; Brans MAD; van de Weg SM; de Kleijn DPV; Sluijter JPG; El Azzouzi H; de Jager SCA
    Sci Rep; 2017 Dec; 7(1):17045. PubMed ID: 29213128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
    Kumar V; Ali SR; Konrad S; Zwirner J; Verbeek JS; Schmidt RE; Gessner JE
    J Clin Invest; 2006 Feb; 116(2):512-20. PubMed ID: 16453025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.